CNEY (CNEY) Stock Price & Analysis
CNEY (CNEY) fell 18.81% to USD 0.58 as of July 25, 2026 at 05:23 UTC, according to Nexqual real-time market data.
CNEY last closed at USD 0.71; the session ranged USD 0.56–0.73 on volume of 725,920 shares. Market capitalization is $4.74M, with a 52-week range of USD 0.31–2.95 (NCM). Source: Nexqual, July 25, 2026 at 05:23 UTC.
Key Statistics (as of July 25, 2026 at 05:23 UTC)
| Price | USD 0.58 |
|---|---|
| Change | ▼ 18.81% (down) |
| Previous Close | USD 0.71 |
| Open | USD 0.69 |
| Day Range | USD 0.56 – 0.73 |
| 52-Week Range | USD 0.31 – 2.95 |
| Volume | 725,920 shares |
| Market Cap | $4.74M |
| Exchange | NCM |
Technical Analysis (CNEY)
Nexqual's technical model rates CNEY "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 05:23 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 44.21 (neutral) |
| vs SMA50 | Below (USD 0.85) |
| MACD | -0.03 (negative) |
Analyst Ratings (CNEY)
Wall Street analysts rate CNEY "None", per Nexqual as of July 25, 2026 at 05:23 UTC.
| Consensus Rating | None |
|---|
Earnings (CNEY)
Source: Nexqual, July 25, 2026 at 05:23 UTC.
Financials & Fundamentals (CNEY)
| Total Revenue | $35.57M |
|---|---|
| Revenue Growth (YoY) | -2.40% |
| Gross Margin | +1.82% |
| Operating Margin | -89.92% |
| Profit Margin | -31.32% |
| ROE | -11.20% |
| Debt / Equity | 3.37 |
| Current Ratio | 13.9 |
| Total Cash | $390,706 |
| Total Debt | $3.43M |
| Free Cash Flow | $-9.81M |
Source: Nexqual, July 25, 2026 at 05:23 UTC.
Financial Health Score (CNEY)
Nexqual rates CNEY's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 05:23 UTC.
| Growth | Weak — Revenue -2% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $391K cash vs $3M debt |
| Cash Flow | Weak — Operating cash flow -$2M |
| Efficiency | Critical — ROE -11%, ROA -6.7% |
Ownership (CNEY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +3.32% |
| Shares Outstanding | 7.57M |
| Float | 4.99M |
| Short % of Float | +4.00% |
Source: Nexqual, July 25, 2026 at 05:23 UTC.
Leadership (CNEY)
CNEY is led by Wenhua Liu (age 55), Interim CEO & Director, per Nexqual as of July 25, 2026 at 05:23 UTC.
| Interim CEO & Director | Wenhua Liu (age 55) |
|---|---|
| Chief Financial Officer | Jinwu Huang (age 50) |
Major Backers & Investors (CNEY)
Notable institutional backers of CNEY include Renaissance Technologies, Xtx Topco Ltd, Virtu Financial LLC, according to Nexqual as of July 25, 2026 at 05:23 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 0.98% |
| Xtx Topco Ltd | 0.37% |
| Virtu Financial LLC | 0.35% |
| Citadel | 0.32% |
| Two Sigma Securities, LLC | 0.17% |
Source: Nexqual, July 25, 2026 at 05:23 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| QH | Quhuo Limited - American Deposi | USD 5.38 | ▲ 1.32% |
| BAOS | Baosheng Media Group Holdings L | USD 1.17 | ▼ 38.1% |
| BON | Bon Natural Life Limited | USD 1.14 | ▼ 5% |
| BBLG | Bone Biologics Corp | USD 1.07 | ▼ 2.73% |
| TNON | Tenon Medical, Inc. | USD 0.19 | ▼ 3.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:23 UTC. This page is informational and not investment advice.